AJP - Endocrinology and Metabolism, Vol 253, Issue 5 E551-E564, Copyright © 1987 by American Physiological Society

ARTICLES

Models to interpret kinetic data in stable isotope tracer studies

C. Cobelli, G. Toffolo, D. M. Bier and R. Nosadini
Department of Electronics and Informatics, University of Padua, Italy.

In contrast to "weightless" radioactive tracers, stable isotope tracers have nonnegligible mass and are naturally present in the system, and the measured variable is a ratio of two isotopic species. These features do not allow stable isotopic tracer data analysis using straightforward analogy with radioactive tracer approaches, even though this practice is common. In this study, we present kinetic variables, models, and measurements for the analysis and interpretation of stable isotope tracer data. Assumptions and mathematical techniques for modeling the data when perturbation is both nonnegligible and negligible are discussed. Emphasis is placed on the rich information content of the dynamic portion of a stable isotope tracer curve and on the role of compartmental and noncompartmental modeling approaches for its interpretation. A presumed and commonly used analogy between the radioactive specific activity and stable isotopic enrichment is shown to be incorrect. We show that the proper analogue of specific activity is the tracer-to-tracee molar ratio. This variable is not a directly measurable one, but a formula is derived that allows its computation from the data. A method for reconstructing the time course in blood of the concentration component due to endogenous synthesis is presented. This allows measurement of the extent of the perturbation in the case where a nonweightless tracer is used. Special attention is given to data analysis originating from a multiple tracer experiment, a configuration necessary for studying more complex systems, e.g., the kinetics of interacting substrates.

This article has been cited by other articles:

				R. Ramakrishnan Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments J. Lipid Res., December 1, 2006; 47(12): 2738 - 2753. [Abstract] [Full Text] [PDF]

				S. Bramswig, A. Kerksiek, T. Sudhop, C. Luers, K. Von Bergmann, and H. K. Berthold Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H704 - H716. [Abstract] [Full Text] [PDF]

				Z. Sun, F. K Welty, G. G Dolnikowski, A. H Lichtenstein, and E. J Schaefer Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma Am. J. Clinical Nutrition, September 1, 2001; 74(3): 308 - 314. [Abstract] [Full Text]

				P. Piatti, L. D. Monti, G. Valsecchi, F. Magni, E. Setola, F. Marchesi, M. Galli-Kienle, G. Pozza, and K. G. M.M. Alberti Long-Term Oral L-Arginine Administration Improves Peripheral and Hepatic Insulin Sensitivity in Type 2 Diabetic Patients Diabetes Care, May 1, 2001; 24(5): 875 - 880. [Abstract] [Full Text]

				I. J. Griffin, J. C. King, and S. A. Abrams Body Weight-Specific Zinc Compartmental Masses in Girls Significantly Exceed Those Reported in Adults: A Stable Isotope Study Using a Kinetic Model J. Nutr., October 1, 2000; 130(10): 2607 - 2612. [Abstract] [Full Text]

				W. Velez-Carrasco, A. H. Lichtenstein, Z. Li, G. G. Dolnikowski, S. Lamon-Fava, F. K. Welty, and E. J. Schaefer Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [2H3]Leucine in Middle-Aged and Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 801 - 806. [Abstract] [Full Text] [PDF]

				F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, and E. J. Schaefer Human Apolipoprotein (Apo) B-48 and ApoB-100 Kinetics With Stable Isotopes Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2966 - 2974. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, A. R. Coggan, and R. R. Wolfe Assessment of methods for improving tracer estimation of non-steady-state rate of appearance J Appl Physiol, November 1, 1999; 87(5): 1813 - 1822. [Abstract] [Full Text] [PDF]

				W. Vélez-Carrasco, A. H. Lichtenstein, P. H. R. Barrett, Z. Sun, G. G. Dolnikowski, F. K. Welty, and E. J. Schaefer Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins J. Lipid Res., September 1, 1999; 40(9): 1695 - 1700. [Abstract] [Full Text]

				W. Velez-Carrasco, A. H. Lichtenstein, F. K. Welty, Z. Li, S. Lamon-Fava, G. G. Dolnikowski, and E. J. Schaefer Dietary Restriction of Saturated Fat and Cholesterol Decreases HDL ApoA-I Secretion Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 918 - 924. [Abstract] [Full Text] [PDF]

				P. Vicini, J. J. Zachwieja, K. E. Yarasheski, D. M. Bier, A. Caumo, and C. Cobelli Glucose production during an IVGTT by deconvolution: validation with the tracer-to-tracee clamp technique Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E285 - E294. [Abstract] [Full Text] [PDF]

				K. Berneis, R. Ninnis, D. Haussinger, and U. Keller Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E188 - E195. [Abstract] [Full Text] [PDF]

				F. Pont, L. Duvillard, B. Verges, and P. Gambert Development of Compartmental Models in Stable-Isotope Experiments : Application to Lipid Metabolism Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 853 - 860. [Abstract] [Full Text] [PDF]

				H. Zulewski, R. Ninnis, A. R. Miserez, M. W. Baumstark, and U. Keller VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100 J. Lipid Res., February 1, 1998; 39(2): 380 - 387. [Abstract] [Full Text]

				F. K. Welty, A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, J. M. Ordovas, and E. J. Schaefer Decreased Production and Increased Catabolism of Apolipoprotein B-100 in Apolipoprotein B-67/B-100 Heterozygotes Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 881 - 888. [Abstract] [Full Text]

				C. A. Aguilar-Salinas, P. H. R. Barrett, J. Pulai, X. L. Zhu, G. Schonfeld, and G Schonfeld A Familial Combined Hyperlipidemic Kindred With Impaired Apolipoprotein B Catabolism: Kinetics of Apolipoprotein B During Placebo and Pravastatin Therapy Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 72 - 82. [Abstract] [Full Text]

				C. A. Aguilar-Salinas, P. H. R. Barrett, K. G. Parhofer, S. G. Young, D. Tessereau, J. Bateman, C. Quinn, and G. Schonfeld Apoprotein B-100 Production Is Decreased in Subjects Heterozygous for Truncations of Apoprotein B Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 71 - 80. [Abstract] [Full Text]